← Leaderboards
Anthony Brent Daniels
Vanderbilt University Medical Center
$1,134,059
Attributed
$1,482,927
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $523.3K · FY2017–23$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,482,927 · 2
By mechanism
K08$959,625 · 1
R01$523,302 · 1
Top collaborators
- Timothy W Corson1 shared
- Yoon Yeo1 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Debra L Friedman$19,684,821
- Md Imam Uddin$2,910,577
Others in their field
Other Emerging Leaders on “Retina”
- Ionut Bebu · George Washington University$13,200,226
- Barbara Halina Braffett · George Washington University$13,200,226
- Jessica Alber · University Of Rhode Island$8,807,713
- Ji Yi · Johns Hopkins University$7,340,265
- Ruchira Singh · University Of Rochester$7,225,302
- Bryan William Jones · Utah State Higher Education System--University Of Utah$6,451,684
Research focus
RetinaEnsureIn VivoPreventNovel TherapeuticsIntravitreal InjectionDrug KineticsIn VitroModalityPharmaceutical PreparationsToxic EffectOryctolagus CuniculusBlindnessLeadAnimal ModelDrug Delivery SystemsAnimal Cancer ModelBaseClinical ResearchAwardCancer TherapyAffectClinical PracticeCountry
Grant awards (6)
Long-acting formulations of griseofulvin for ocular neovascularization therapy$523,302
R01 · FY2023 · EY
Developing alternative approaches to reduce retinal toxicity and prevent vision loss in the treatment of intraocular retinoblastoma$191,925
K08 · FY2021 · EY · contact PI
Developing alternative approaches to reduce retinal toxicity and prevent vision loss in the treatment of intraocular retinoblastoma$191,925
K08 · FY2020 · EY · contact PI
Developing alternative approaches to reduce retinal toxicity and prevent vision loss in the treatment of intraocular retinoblastoma$191,925
K08 · FY2019 · EY · contact PI
Developing alternative approaches to reduce retinal toxicity and prevent vision loss in the treatment of intraocular retinoblastoma$191,925
K08 · FY2018 · EY · contact PI
Developing alternative approaches to reduce retinal toxicity and prevent vision loss in the treatment of intraocular retinoblastoma$191,925
K08 · FY2017 · EY · contact PI